protocolSection identificationModule nctId: NCT06365255, orgStudyIdInfo id: 2022-A01453-40, briefTitle: National Epidemiological Study of the Possible Impact of Stress on Glycaemic Control in Patients With Type 1 Diabetes, acronym: EPISTRESS2, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-01-17, primaryCompletionDateStruct date: 2024-02-28, completionDateStruct date: 2024-02-28, studyFirstPostDateStruct date: 2024-04-15, lastUpdatePostDateStruct date: 2024-04-17, sponsorCollaboratorsModule leadSponsor name: Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète, class: OTHER, descriptionModule briefSummary: The EPISTRESS2 study is a one-off cross-sectional epidemiological survey, carried out via an online form in patients with type 1 diabetes followed up by participating investigating centres.In type 1 diabetes (T1DM), studies on stress and its impact on glycaemia have led to ambiguous results, mainly because there are no solid epidemiological or experimental data in the literature. The aim of this study was to assess the impact of perceived stress on blood glucose levels in a population of subjects with T1DM at 10 national centres., conditionsModule conditions: Diabetes Type 1, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: OTHER, enrollmentInfo count: 1344, type: ACTUAL, armsInterventionsModule interventions name: questionnaires, outcomesModule primaryOutcomes measure: The primary endpoint is the characterisation of 4 profiles of patients with type 1 diabetes on insulin pumps., secondaryOutcomes measure: Identify sub-populations of patients who feel stressed, secondaryOutcomes measure: Establish and categorise the different stress factors, secondaryOutcomes measure: Establishing a relationship between personality type and the impact of stress, secondaryOutcomes measure: Evaluation of the quality of life score obtained according to the 4 profiles and/or personalities, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Angers University Hospital, city: Angers, zip: 49100, country: France, geoPoint lat: 47.46667, lon: -0.55, locations facility: Avignon Hospital, city: Avignon, zip: 84000, country: France, geoPoint lat: 43.94834, lon: 4.80892, locations facility: St André Hospital, city: Bordeaux, zip: 33076, country: France, geoPoint lat: 44.84044, lon: -0.5805, locations facility: Brest University Hospital, city: Brest, zip: 29200, country: France, geoPoint lat: 48.3903, lon: -4.48628, locations facility: Dijon University Hospital, city: Dijon, zip: 21079, country: France, geoPoint lat: 47.31667, lon: 5.01667, locations facility: CERITD, city: Evry, zip: 91058, country: France, geoPoint lat: 48.63333, lon: 2.45, locations facility: Grenoble University Hospital, city: Grenoble, zip: 38043, country: France, geoPoint lat: 45.16667, lon: 5.71667, locations facility: Lille University Hospital, city: Lille, zip: 59037, country: France, geoPoint lat: 50.63297, lon: 3.05858, locations facility: APHM- La Conception Hospital, city: Marseille, zip: 13000, country: France, geoPoint lat: 43.29551, lon: 5.38958, locations facility: Private practice in endocrinology and metabolic diseases, city: Mérignac, zip: 33700, country: France, geoPoint lat: 44.83248, lon: -0.63381, locations facility: Srasbourg University Hospital, city: Strasbourg, zip: 67091, country: France, geoPoint lat: 48.58392, lon: 7.74553, hasResults: False